Development of a LiDia-SEQ™ platform compatible breast cancer panel and testing with metastatic breast cancer patient samples: A rapid, sample-to-result, fully integrated next-generation sequencing (NGS)-based platform, LiDia-SEQ, for use at the point-of-need.

Saved in:
Bibliographic Details
Title: Development of a LiDia-SEQ™ platform compatible breast cancer panel and testing with metastatic breast cancer patient samples: A rapid, sample-to-result, fully integrated next-generation sequencing (NGS)-based platform, LiDia-SEQ, for use at the point-of-need.
Authors: Ramsheh MY; Department of Surgery and Cancer, Division of Cancer, Imperial College London, London, UK.; DNAe Group Holdings Ltd, Scale Space, 58 Wood Lane, London, W12 7RZ, UK., Fraccari RL; DNAe Group Holdings Ltd, Scale Space, 58 Wood Lane, London, W12 7RZ, UK., Christova R; DNAe Group Holdings Ltd, Scale Space, 58 Wood Lane, London, W12 7RZ, UK., Killpack J; DNAe Group Holdings Ltd, Scale Space, 58 Wood Lane, London, W12 7RZ, UK., Acquah JR; DNAe Group Holdings Ltd, Scale Space, 58 Wood Lane, London, W12 7RZ, UK., Nteliopoulos G; Department of Surgery and Cancer, Division of Cancer, Imperial College London, London, UK., Wren E; Department of Surgery and Cancer, Division of Cancer, Imperial College London, London, UK.; Department of Medical Oncology, Imperial College Healthcare Trust, Charing Cross Hospital, London, UK., Rehman F; Department of Surgery and Cancer, Division of Cancer, Imperial College London, London, UK.; Department of Medical Oncology, Imperial College Healthcare Trust, Charing Cross Hospital, London, UK., Page K; Leicester Cancer Research Centre, School of Medical Sciences, University of Leicester, Leicester, UK., Shaw JA; Leicester Cancer Research Centre, School of Medical Sciences, University of Leicester, Leicester, UK., Saha A; DNAe Group Holdings Ltd, Scale Space, 58 Wood Lane, London, W12 7RZ, UK., Wong R; Department of Surgery and Cancer, Division of Cancer, Imperial College London, London, UK.; DNAe Group Holdings Ltd, Scale Space, 58 Wood Lane, London, W12 7RZ, UK., Pradhan S; DNAe Group Holdings Ltd, Scale Space, 58 Wood Lane, London, W12 7RZ, UK., Novotny P; DNAe Group Holdings Ltd, Scale Space, 58 Wood Lane, London, W12 7RZ, UK., Peras M; DNAe Group Holdings Ltd, Scale Space, 58 Wood Lane, London, W12 7RZ, UK., Arnold B; DNAe Group Holdings Ltd, Scale Space, 58 Wood Lane, London, W12 7RZ, UK., Wisniewski M; DNAe Group Holdings Ltd, Scale Space, 58 Wood Lane, London, W12 7RZ, UK., Joshi H; DNAe Group Holdings Ltd, Scale Space, 58 Wood Lane, London, W12 7RZ, UK., Coombes RC; Department of Surgery and Cancer, Division of Cancer, Imperial College London, London, UK., Reed S; DNAe Group Holdings Ltd, Scale Space, 58 Wood Lane, London, W12 7RZ, UK.
Source: The journal of liquid biopsy [J Liq Biopsy] 2026 Jun 02; Vol. 12, pp. 100474. Date of Electronic Publication: 2026 Jun 02 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: United States NLM ID: 9918957761506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-1954 (Electronic) Linking ISSN: 29501954 NLM ISO Abbreviation: J Liq Biopsy Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2950-1954
DOI:10.1016/j.jlb.2026.100474